ZNF330 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.369430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.077000E-01
Normal-vs-Stage2
1.509630E-01
Normal-vs-Stage3
9.305700E-02
Normal-vs-Stage4
8.407400E-01
Stage1-vs-Stage2
7.698400E-01
Stage1-vs-Stage3
6.478300E-02
Stage1-vs-Stage4
2.830400E-01
Stage2-vs-Stage3
2.074000E-01
Stage2-vs-Stage4
1.928850E-01
Stage3-vs-Stage4
8.674000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.404830E-01
Normal-vs-AfricanAmerican
3.222600E-01
Normal-vs-Asian
1.030410E-01
Caucasian-vs-AfricanAmerican
9.171200E-01
Caucasian-vs-Asian
1.781980E-01
AfricanAmerican-vs-Asian
4.044000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.657980E-01
Normal-vs-Female
1.167840E-01
Male-vs-Female
6.858200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.789200E-01
Normal-vs-Age(41-60Yrs)
1.755640E-01
Normal-vs-Age(61-80Yrs)
1.367170E-01
Normal-vs-Age(81-100Yrs)
1.832770E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.877200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.332000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.065600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.362300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.630800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.235400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.422400E-02
Normal-vs-Daily Drinker
4.178200E-02
Normal-vs-Weekly Drinker
2.837200E-01
Normal-vs-Occasional Drinker
2.082400E-01
Normal-vs-Social Drinker
3.323400E-01
Non Drinker-vs-Daily Drinker
5.954000E-01
Non Drinker-vs-Weekly Drinker
7.000400E-01
Non Drinker-vs-Occasional Drinker
2.108200E-01
Non Drinker-vs-Social Drinker
2.293400E-01
Daily Drinker-vs-Weekly Drinker
4.521800E-01
Daily Drinker-vs-Occasional Drinker
7.984100E-02
Daily Drinker-vs-Social Drinker
1.068560E-01
Weekly Drinker-vs-Occasional Drinker
5.847200E-01
Weekly Drinker-vs-Social Drinker
5.799000E-01
Occasional Drinker-vs-Social Drinker
9.119000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.813800E-01
Normal-vs-Grade 2
6.408800E-01
Normal-vs-Grade 3
6.448600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.478240E-01
Grade 1-vs-Grade 3
1.831030E-01
Grade 1-vs-Grade 4
3.813800E-01
Grade 2-vs-Grade 3
9.295000E-01
Grade 2-vs-Grade 4
6.408800E-01
Grade 3-vs-Grade 4
6.448600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.273400E-01
Normal-vs-NonDiabetic
8.565900E-02
Diabetic-vs-NonDiabetic
5.953600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.206800E-01
Normal-vs-NoPancreatitis
1.087370E-01
Pancreatitis-vs-NoPancreatitis
5.435400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.792300E-02
Normal-vs-N1
1.795960E-01
N0-vs-N1
5.969400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.323180E-01
Normal-vs-TP53-NonMutant
2.956200E-01
TP53-Mutant-vs-TP53-NonMutant
5.098400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
